The DAMO PANDA can accurately detect pancreatic cancer lesions, and FDA breakthrough therapy designation aims to accelerate ...

Ethakota, J. , Singh, B. , Bai, S. , Tareen, H. , Kumar, D. and Malik, D. (2025) The Role of Artificial Intelligence in ...

Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially ...

In the US, the incidence of pancreatic cancer is increasing in patients of all ages, and the incidence of colorectal cancer is increasing in patients aged 15-34 years.

A study published April 14 by JAMA Network Open found that rates of pancreatic and colon cancer rose among young adults from ...

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic “marks” in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...

Dr. Gabriel Rabinovich, one of the collaborating scientists, added that targeting Galectin-1—both inside and outside ...

The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...

A new discovery by researchers at Cold Spring Harbor Laboratory shows promise for the possible early treatment and prevention ...

The "KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The global market for KRAS inhibitors has seen ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.